Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion type Assertion NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_head.
- NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion description "[Recently, it has become clear that patients meeting WHO criteria for RARS-T have clonal JAK2(V617F) and MPL(W515) mutations at a similar rate to essential thrombocythaemia (ET).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_provenance.
- NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion evidence source_evidence_literature NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_provenance.
- NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion SIO_000772 19120370 NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_provenance.
- NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion wasDerivedFrom befree-2016 NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_provenance.
- NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_assertion wasGeneratedBy ECO_0000203 NP712188.RALBjvdOu0bnDwFN0Q1gtnSy6z_njCEXLuQ3qOjGVWH5E130_provenance.